Dr Califf’s name was first floated as a possible candidate to replace action Commissioner Dr Janet MD, in mid October.
Prior experience
Dr Califf led the Agency from February 2016 to the end of the Obama Administration after a year as the agency’s deputy commissioner for medical products and tobacco, according to FDA’s website. He was succeeded as commissioner by Dr Scott Gottlieb, MD.
Dr Califf received his MD at Duke University Medical School and served as a professor of cardiology at the school. He founded and directed the Duke Clinical Research Institute at the school, which at the time he was first nominated to lead FDA had a budget of more than $320 million.
Trade organizations active in the dietary supplement reacted positively to the news with a few caveats.
“Dr. Califf is an excellent choice to lead the Agency at such an important time for public health. In addition, his experience and insights on digital health and technology will be critical for helping to shape the future of FDA and the growth of consumer self-care,” said Scott Melville, president and CEO of the Consumer Healthcare Products Association.
“Once confirmed, we look forward to continuing to work with the new commissioner on shared priorities to strengthen the safety and accessibility of self-care options,” Melville added.
“We support his confirmation and will look forward to working with Dr. Califf and FDA leadership to strengthen the dietary supplement industry,” said Steve Mister, president and CEO of the Council for Responsible Nutrition.